Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

Clinical trial NCT07010835 · RECRUITING

Trial details

NCT number: NCT07010835
Sponsor: Excyte Biopharma Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)

Start date: 2025-08-25
Primary completion: 2027-06-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.